Cardiovascular medicine
Citations 1151-1160 of 25899 total displayed.
Past content
(since Oct 1840):
|
-
- News
- Two hour death in US execution is likely to lead to legal challenges
- Owen Dyer
-
BMJ 2014;349:g4861, doi: 10.1136/bmj.g4861,
-
[Extract]
[Full text]
[PDF]
-
- News
- Maharashtra state prepares to ban smokeless tobacco use in public places from August
- Sanjeet Bagcchi
-
BMJ 2014;349:g4849, doi: 10.1136/bmj.g4849,
-
[Extract]
[Full text]
[PDF]
-
- Practice
- Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance
- Serena Carville, David Wonderling, Paul Stevens on behalf of the Guideline Development Group
-
BMJ 2014;349:g4507, doi: 10.1136/bmj.g4507,
-
[Extract]
[Full text]
[PDF]
-
- Editor's choice
- Dabigatran and statins: faith, hype, and transparency
- Trevor Jackson
-
BMJ 2014;349:g4793, doi: 10.1136/bmj.g4793,
-
[Extract]
[Full text]
[PDF]
-
- News
- Boehringer Ingelheim withheld safety analyses on new anticoagulant, The BMJ investigation finds
- Zosia Kmietowicz
-
BMJ 2014;349:g4756, doi: 10.1136/bmj.g4756,
-
[Extract]
[Full text]
[PDF]
-
- Analysis
- Dabigatran, bleeding, and the regulators
- Thomas J Moore, Michael R Cohen, and Donald R Mattison
-
BMJ 2014;349:g4517, doi: 10.1136/bmj.g4517,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Dabigatran: how the drug company withheld important analyses
- Deborah Cohen
-
BMJ 2014;349:g4670, doi: 10.1136/bmj.g4670,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- The trouble with dabigatran
- Blake Charlton and Rita Redberg
-
BMJ 2014;349:g4681, doi: 10.1136/bmj.g4681,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Concerns over data in key dabigatran trial
- Deborah Cohen
-
BMJ 2014;349:g4747, doi: 10.1136/bmj.g4747,
-
[Extract]
[Full text]
[PDF]
-
- Editorials
- Mass treatment with statins
- Ben Goldacre and Liam Smeeth
-
BMJ 2014;349:g4745, doi: 10.1136/bmj.g4745,
-
[Extract]
[Full text]
[PDF]
|